JOHANNESBURG - There's been a major medical breakthrough in the treatment of drug-resistant TB.
Clinical trials show that a once-daily, six-month course of levofloxacin reduces the risk of contraction by children.
The TB-CHAMP trial was conducted in South Africa and focused on children under 5.
James Seddon, co-lead researcher from the Desmond Tutu TB Centre, discusses this further.